RANI THERAPEUTICS HOLDINGS, INC.

Analyst Reco. Rani Therapeutics Holdings, Inc.

Equities

RANI

US7530181004

Real-time Estimate Cboe BZX Other stock markets 08:42:47 02/07/2024 pm IST			5-day change	1st Jan Change
3.825 ^USD	+0.13%		+2.14%	+15.06%

24/06	Rani Therapeutics Partners With ProGen for Oral Obesity Treatment Development; Shares Rise	MT
24/06	Transcript : Rani Therapeutics Holdings, Inc. - Special Call

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Maxim Starts Coverage on Rani Therapeutics With Buy Rating, $15 Price Target	14/06	MT
UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating	16/05	MT
HC Wainwright Adjusts Price Target on Rani Therapeutics Holdings to $13 From $12, Maintains Buy Rating	07/05	MT
Canaccord Genuity Adjusts Rani Therapeutics Price Target to $9 From $21, Maintains Buy Rating	27/03	MT
HC Wainwright Adjusts Price Target on Rani Therapeutics to $12 From $16, Keeps Buy Rating	25/03	MT
Wedbush Cuts Rani Therapeutics Holdings' PT to $8 From $20, Keeps Outperform Rating	10/11	MT
HC Wainwright Adjusts Price Target on Rani Therapeutics to $16 From $20, Maintains Buy Rating	09/11	MT
HC Wainwright Adjusts Price Target on Rani Therapeutics to $20 From $22, Keeps Buy Rating	14/23/14	MT
Wedbush Lifts Rani Therapeutics Holdings' Price Target to $20 From $19, Keeps Outperform Rating	07/22/07	MT
UBS Initiates Coverage on Rani Therapeutics With Buy Rating, $15 Price Target	11/22/11	MT
Wedbush Adjusts Rani Therapeutics Holdings Price Target to $19 From $17, Maintains Outperform Rating	29/22/29	MT
Wedbush Adjusts Price Target on Rani Therapeutics Holdings to $17 From $28, Keeps Outperform Rating	12/22/12	MT
HC Wainwright Initiates Rani Therapeutics Holdings at Buy With $22 Price Target	27/22/27	MT
Wedbush Starts Rani Therapeutics Holdings at Outperform With $28 Price Target	13/22/13	MT
RANI THERAPEUTICS : Canaccord Genuity Starts Rani Therapeutics Holdings at Buy With $29 Price Target	25/21/25	MT
RANI THERAPEUTICS : BTIG Starts Rani Therapeutics Holdings at Buy With $24 Price Target	25/21/25	MT
RANI THERAPEUTICS : Cantor Fitzgerald Starts Rani Therapeutics Holdings at Overweight with $23 Price Target	24/21/24	MT
RANI THERAPEUTICS : Stifel Starts Rani Therapeutics Holdings at Buy with $24 Price Target	24/21/24	MT
RANI THERAPEUTICS : BofA Securities Starts Rani Therapeutics Holdings at Buy with $23 Price Target	24/21/24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer